A single amino acid residue can determine the sensitivity of SERCAs to artemisinins

Artemisinins are the most important class of antimalarial drugs. They specifically inhibit PfATP6, a SERCA-type ATPase of Plasmodium falciparum. Here we show that a single amino acid in transmembrane segment 3 of SERCAs can determine susceptibility to artemisinin. An L263E replacement of a malarial by a mammalian residue abolishes inhibition by artemisinins. Introducing residues found in other Plasmodium spp. also modulates artemisinin sensitivity, suggesting that artemisinins interact with the thapsigargin-binding cleft of susceptible SERCAs.

[1]  M. Nakasako,et al.  Crystal structure of the calcium pump of sarcoplasmic reticulum at 2.6 Å resolution , 2000, Nature.

[2]  C. Woodrow,et al.  Intraerythrocytic Plasmodium falciparum Expresses a High Affinity Facilitative Hexose Transporter* , 1999, The Journal of Biological Chemistry.

[3]  S. Krishna,et al.  Artemisinins: mechanisms of action and potential for resistance. , 2004, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[4]  C. Wongsrichanalai,et al.  Drug-resistant malaria in Bangladesh: an in vitro assessment. , 2003, The American journal of tropical medicine and hygiene.

[5]  Hiromi Nomura,et al.  Structural changes in the calcium pump accompanying the dissociation of calcium , 2002, Nature.

[6]  D. L. Klayman,et al.  Qinghaosu (artemisinin): an antimalarial drug from China , 1985 .

[7]  D. Warhurst,et al.  Uptake of [3H] dihydroartemisinine by erythrocytes infected with Plasmodium falciparum in vitro. , 1984, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[8]  K. Rieckmann,et al.  Simple In Vitro Assay for Determining the Sensitivity of Plasmodium vivax Isolates from Fresh Human Blood to Antimalarials in Areas where P. vivax Is Endemic , 2003, Antimicrobial Agents and Chemotherapy.

[9]  S. Krishna,et al.  Artemisinins target the SERCA of Plasmodium falciparum , 2003, Nature.

[10]  C. Toyoshima,et al.  Crystal structure of the calcium pump with a bound ATP analogue , 2004, Nature.

[11]  J. Thompson,et al.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.

[12]  A. Rishi,et al.  Specific Substitutions at Amino Acid 256 of the Sarcoplasmic/Endoplasmic Reticulum Ca2+ Transport ATPase Mediate Resistance to Thapsigargin in Thapsigargin-resistant Hamster Cells* , 1998, The Journal of Biological Chemistry.

[13]  A. Cowman,et al.  Analysis of pfcrt, pfmdr1, dhfr, and dhps mutations and drug sensitivities in Plasmodium falciparum isolates from patients in Vietnam before and after treatment with artemisinin. , 2003, The American journal of tropical medicine and hygiene.

[14]  François Nosten,et al.  Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number , 2004, The Lancet.

[15]  Hiromi Nomura,et al.  Lumenal gating mechanism revealed in calcium pump crystal structures with phosphate analogues , 2004, Nature.

[16]  Kenneth J. Arrow,et al.  Saving lives, buying time : economics of malaria drugs in an age of resistance , 2004 .

[17]  P. Newton,et al.  In vitro efficacy of antimalarial drugs against Plasmodium vivax on the western border of Thailand. , 2004, The American journal of tropical medicine and hygiene.

[18]  R. Price,et al.  Plasmodium falciparum antimalarial drug susceptibility on the north-western border of Thailand during five years of extensive use of artesunate-mefloquine. , 2000, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[19]  C. Janse,et al.  Comparison of in vivo and in vitro antimalarial activity of artemisinin, dihydroartemisinin and sodium artesunate in the Plasmodium berghei-rodent model. , 1994, International journal for parasitology.